カテゴリー： LP Information, 世界, 医療/バイオ

心血管インターベンション製品のグローバル市場予測2023-2029

◆英語タイトル：Global Cardiovascular Interventional Product Market Growth 2023-2029
	◆商品コード：LP23MY4300 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：116 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「心血管インターベンション製品のグローバル市場」は、過去の販売実績から2022年の世界の心血管インターベンション製品の総販売量を検討し、2023年から2029年の予測される心血管インターベンション製品の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の心血管インターベンション製品の市場規模を掲載し、XXX百万米ドル規模の世界の心血管インターベンション製品市場の詳細な分析を提供します。本インサイトレポートは、世界の心血管インターベンション製品業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の心血管インターベンション製品市場における各社の独自のポジションをより深く理解するために、心血管インターベンション製品製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の心血管インターベンション製品市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。心血管インターベンション製品の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。心血管インターベンション製品の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。心血管インターベンション製品のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

心血管インターベンション製品の世界主要メーカーとしては、Boston Scientific、 Abbott Laboratories、 Medtronic plc、 TERUMO CORPORATION、 NIPRO、 B. Braun Melsungen AG、 Cook Medical、 MicroPort、 Lepu Medical、 JW Medical Systems (JWMS)、 Intecc、 KANEKA、 Sinomed、 Lifetech、 Gore Medicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の心血管インターベンション製品市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では心血管インターベンション製品市場をセグメンテーションし、種類別 (冠状動脈ステント、PTCAバルーンカテーテル、ガイドワイヤー、その他)、用途別 (狭心症、心筋梗塞、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：冠状動脈ステント、PTCAバルーンカテーテル、ガイドワイヤー、その他

・用途別区分：狭心症、心筋梗塞、その他

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の心血管インターベンション製品市場の10年間の市場状況・展望は？
・世界および地域別に見た心血管インターベンション製品市場成長の要因は何か？
・心血管インターベンション製品の市場機会はエンドマーケットの規模によってどのように変化するのか？
・心血管インターベンション製品のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：心血管インターベンション製品の年間販売量2018-2029、地域別現状・将来分析
・心血管インターベンション製品の種類別セグメント：冠状動脈ステント、PTCAバルーンカテーテル、ガイドワイヤー、その他
・心血管インターベンション製品の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・心血管インターベンション製品の用途別セグメント：狭心症、心筋梗塞、その他
・心血管インターベンション製品の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の心血管インターベンション製品市場
・企業別のグローバル心血管インターベンション製品市場データ：2018-2023年の年間販売量、市場シェア
・企業別の心血管インターベンション製品の年間売上：2018-2023年の売上、市場シェア
・企業別の心血管インターベンション製品販売価格
・主要企業の心血管インターベンション製品生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

心血管インターベンション製品の地域別レビュー
・地域別の心血管インターベンション製品市場規模2018-2023：年間販売量、売上
・主要国別の心血管インターベンション製品市場規模2018-2023：年間販売量、売上
・南北アメリカの心血管インターベンション製品販売の成長
・アジア太平洋の心血管インターベンション製品販売の成長
・ヨーロッパの心血管インターベンション製品販売の成長
・中東・アフリカの心血管インターベンション製品販売の成長

南北アメリカ市場
・南北アメリカの国別の心血管インターベンション製品販売量、売上（2018-2023）
・南北アメリカの心血管インターベンション製品の種類別販売量
・南北アメリカの心血管インターベンション製品の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の心血管インターベンション製品販売量、売上（2018-2023）
・アジア太平洋の心血管インターベンション製品の種類別販売量
・アジア太平洋の心血管インターベンション製品の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の心血管インターベンション製品販売量、売上（2018-2023）
・ヨーロッパの心血管インターベンション製品の種類別販売量
・ヨーロッパの心血管インターベンション製品の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の心血管インターベンション製品販売量、売上（2018-2023）
・中東・アフリカの心血管インターベンション製品の種類別販売量
・中東・アフリカの心血管インターベンション製品の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・心血管インターベンション製品の製造コスト構造分析
・心血管インターベンション製品の製造プロセス分析
・心血管インターベンション製品の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・心血管インターベンション製品の主要なグローバル販売業者
・心血管インターベンション製品の主要なグローバル顧客

地域別の心血管インターベンション製品市場予測レビュー
・地域別の心血管インターベンション製品市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・心血管インターベンション製品の種類別市場規模予測
・心血管インターベンション製品の用途別市場規模予測

主要企業分析
Boston Scientific、 Abbott Laboratories、 Medtronic plc、 TERUMO CORPORATION、 NIPRO、 B. Braun Melsungen AG、 Cook Medical、 MicroPort、 Lepu Medical、 JW Medical Systems (JWMS)、 Intecc、 KANEKA、 Sinomed、 Lifetech、 Gore Medical
・企業情報
・心血管インターベンション製品製品
・心血管インターベンション製品販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Cardiovascular Interventional Product Industry Forecast” looks at past sales and reviews total world Cardiovascular Interventional Product sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiovascular Interventional Product sales for 2023 through 2029. With Cardiovascular Interventional Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Interventional Product industry.
This Insight Report provides a comprehensive analysis of the global Cardiovascular Interventional Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Interventional Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiovascular Interventional Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Interventional Product and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Interventional Product.
The global Cardiovascular Interventional Product market size is projected to grow from US$ 10020 million in 2022 to US$ 14080 million in 2029; it is expected to grow at a CAGR of 14080 from 2023 to 2029.
Global key players of Cardiovascular Interventional Product include Boston Scientific, Abbott Laboratories, Medtronic plc, TERUMO CORPORATION and NIPRO, etc. Top five players occupy for a share about 75%. North America is the largest market, with a share about 47%, followed by Japan and Europe. In terms of product, Coronary Stent is the largest segment, with a share over 62%. In terms of application, Angina is the largest market, with a share over 60%.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Interventional Product market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Coronary Stent
PTCA Balloon Catheter
Guide Wire
Other
Segmentation by application
Angina
Miocardial Infarction
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Boston Scientific
Abbott Laboratories
Medtronic plc
TERUMO CORPORATION
NIPRO
B. Braun Melsungen AG
Cook Medical
MicroPort
Lepu Medical
JW Medical Systems (JWMS)
Intecc
KANEKA
Sinomed
Lifetech
Gore Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cardiovascular Interventional Product market?
What factors are driving Cardiovascular Interventional Product market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cardiovascular Interventional Product market opportunities vary by end market size?
How does Cardiovascular Interventional Product break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiovascular Interventional Product Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cardiovascular Interventional Product by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cardiovascular Interventional Product by Country/Region, 2018, 2022 & 2029
2.2 Cardiovascular Interventional Product Segment by Type
2.2.1 Coronary Stent
2.2.2 PTCA Balloon Catheter
2.2.3 Guide Wire
2.2.4 Other
2.3 Cardiovascular Interventional Product Sales by Type
2.3.1 Global Cardiovascular Interventional Product Sales Market Share by Type (2018-2023)
2.3.2 Global Cardiovascular Interventional Product Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cardiovascular Interventional Product Sale Price by Type (2018-2023)
2.4 Cardiovascular Interventional Product Segment by Application
2.4.1 Angina
2.4.2 Miocardial Infarction
2.4.3 Other
2.5 Cardiovascular Interventional Product Sales by Application
2.5.1 Global Cardiovascular Interventional Product Sale Market Share by Application (2018-2023)
2.5.2 Global Cardiovascular Interventional Product Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cardiovascular Interventional Product Sale Price by Application (2018-2023)
3 Global Cardiovascular Interventional Product by Company
3.1 Global Cardiovascular Interventional Product Breakdown Data by Company
3.1.1 Global Cardiovascular Interventional Product Annual Sales by Company (2018-2023)
3.1.2 Global Cardiovascular Interventional Product Sales Market Share by Company (2018-2023)
3.2 Global Cardiovascular Interventional Product Annual Revenue by Company (2018-2023)
3.2.1 Global Cardiovascular Interventional Product Revenue by Company (2018-2023)
3.2.2 Global Cardiovascular Interventional Product Revenue Market Share by Company (2018-2023)
3.3 Global Cardiovascular Interventional Product Sale Price by Company
3.4 Key Manufacturers Cardiovascular Interventional Product Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiovascular Interventional Product Product Location Distribution
3.4.2 Players Cardiovascular Interventional Product Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cardiovascular Interventional Product by Geographic Region
4.1 World Historic Cardiovascular Interventional Product Market Size by Geographic Region (2018-2023)
4.1.1 Global Cardiovascular Interventional Product Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cardiovascular Interventional Product Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cardiovascular Interventional Product Market Size by Country/Region (2018-2023)
4.2.1 Global Cardiovascular Interventional Product Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cardiovascular Interventional Product Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cardiovascular Interventional Product Sales Growth
4.4 APAC Cardiovascular Interventional Product Sales Growth
4.5 Europe Cardiovascular Interventional Product Sales Growth
4.6 Middle East & Africa Cardiovascular Interventional Product Sales Growth
5 Americas
5.1 Americas Cardiovascular Interventional Product Sales by Country
5.1.1 Americas Cardiovascular Interventional Product Sales by Country (2018-2023)
5.1.2 Americas Cardiovascular Interventional Product Revenue by Country (2018-2023)
5.2 Americas Cardiovascular Interventional Product Sales by Type
5.3 Americas Cardiovascular Interventional Product Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiovascular Interventional Product Sales by Region
6.1.1 APAC Cardiovascular Interventional Product Sales by Region (2018-2023)
6.1.2 APAC Cardiovascular Interventional Product Revenue by Region (2018-2023)
6.2 APAC Cardiovascular Interventional Product Sales by Type
6.3 APAC Cardiovascular Interventional Product Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cardiovascular Interventional Product by Country
7.1.1 Europe Cardiovascular Interventional Product Sales by Country (2018-2023)
7.1.2 Europe Cardiovascular Interventional Product Revenue by Country (2018-2023)
7.2 Europe Cardiovascular Interventional Product Sales by Type
7.3 Europe Cardiovascular Interventional Product Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cardiovascular Interventional Product by Country
8.1.1 Middle East & Africa Cardiovascular Interventional Product Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cardiovascular Interventional Product Revenue by Country (2018-2023)
8.2 Middle East & Africa Cardiovascular Interventional Product Sales by Type
8.3 Middle East & Africa Cardiovascular Interventional Product Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cardiovascular Interventional Product
10.3 Manufacturing Process Analysis of Cardiovascular Interventional Product
10.4 Industry Chain Structure of Cardiovascular Interventional Product
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cardiovascular Interventional Product Distributors
11.3 Cardiovascular Interventional Product Customer
12 World Forecast Review for Cardiovascular Interventional Product by Geographic Region
12.1 Global Cardiovascular Interventional Product Market Size Forecast by Region
12.1.1 Global Cardiovascular Interventional Product Forecast by Region (2024-2029)
12.1.2 Global Cardiovascular Interventional Product Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cardiovascular Interventional Product Forecast by Type
12.7 Global Cardiovascular Interventional Product Forecast by Application
13 Key Players Analysis
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Cardiovascular Interventional Product Product Portfolios and Specifications
13.1.3 Boston Scientific Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Cardiovascular Interventional Product Product Portfolios and Specifications
13.2.3 Abbott Laboratories Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Medtronic plc
13.3.1 Medtronic plc Company Information
13.3.2 Medtronic plc Cardiovascular Interventional Product Product Portfolios and Specifications
13.3.3 Medtronic plc Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medtronic plc Main Business Overview
13.3.5 Medtronic plc Latest Developments
13.4 TERUMO CORPORATION
13.4.1 TERUMO CORPORATION Company Information
13.4.2 TERUMO CORPORATION Cardiovascular Interventional Product Product Portfolios and Specifications
13.4.3 TERUMO CORPORATION Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 TERUMO CORPORATION Main Business Overview
13.4.5 TERUMO CORPORATION Latest Developments
13.5 NIPRO
13.5.1 NIPRO Company Information
13.5.2 NIPRO Cardiovascular Interventional Product Product Portfolios and Specifications
13.5.3 NIPRO Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 NIPRO Main Business Overview
13.5.5 NIPRO Latest Developments
13.6 B. Braun Melsungen AG
13.6.1 B. Braun Melsungen AG Company Information
13.6.2 B. Braun Melsungen AG Cardiovascular Interventional Product Product Portfolios and Specifications
13.6.3 B. Braun Melsungen AG Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 B. Braun Melsungen AG Main Business Overview
13.6.5 B. Braun Melsungen AG Latest Developments
13.7 Cook Medical
13.7.1 Cook Medical Company Information
13.7.2 Cook Medical Cardiovascular Interventional Product Product Portfolios and Specifications
13.7.3 Cook Medical Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cook Medical Main Business Overview
13.7.5 Cook Medical Latest Developments
13.8 MicroPort
13.8.1 MicroPort Company Information
13.8.2 MicroPort Cardiovascular Interventional Product Product Portfolios and Specifications
13.8.3 MicroPort Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 MicroPort Main Business Overview
13.8.5 MicroPort Latest Developments
13.9 Lepu Medical
13.9.1 Lepu Medical Company Information
13.9.2 Lepu Medical Cardiovascular Interventional Product Product Portfolios and Specifications
13.9.3 Lepu Medical Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Lepu Medical Main Business Overview
13.9.5 Lepu Medical Latest Developments
13.10 JW Medical Systems (JWMS)
13.10.1 JW Medical Systems (JWMS) Company Information
13.10.2 JW Medical Systems (JWMS) Cardiovascular Interventional Product Product Portfolios and Specifications
13.10.3 JW Medical Systems (JWMS) Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 JW Medical Systems (JWMS) Main Business Overview
13.10.5 JW Medical Systems (JWMS) Latest Developments
13.11 Intecc
13.11.1 Intecc Company Information
13.11.2 Intecc Cardiovascular Interventional Product Product Portfolios and Specifications
13.11.3 Intecc Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Intecc Main Business Overview
13.11.5 Intecc Latest Developments
13.12 KANEKA
13.12.1 KANEKA Company Information
13.12.2 KANEKA Cardiovascular Interventional Product Product Portfolios and Specifications
13.12.3 KANEKA Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 KANEKA Main Business Overview
13.12.5 KANEKA Latest Developments
13.13 Sinomed
13.13.1 Sinomed Company Information
13.13.2 Sinomed Cardiovascular Interventional Product Product Portfolios and Specifications
13.13.3 Sinomed Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sinomed Main Business Overview
13.13.5 Sinomed Latest Developments
13.14 Lifetech
13.14.1 Lifetech Company Information
13.14.2 Lifetech Cardiovascular Interventional Product Product Portfolios and Specifications
13.14.3 Lifetech Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Lifetech Main Business Overview
13.14.5 Lifetech Latest Developments
13.15 Gore Medical
13.15.1 Gore Medical Company Information
13.15.2 Gore Medical Cardiovascular Interventional Product Product Portfolios and Specifications
13.15.3 Gore Medical Cardiovascular Interventional Product Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Gore Medical Main Business Overview
13.15.5 Gore Medical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Cardiovascular Interventional Product Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Cardiovascular Interventional Product Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Coronary Stent
Table 4. Major Players of PTCA Balloon Catheter
Table 5. Major Players of Guide Wire
Table 6. Major Players of Other
Table 7. Global Cardiovascular Interventional Product Sales by Type (2018-2023) & (K Units)
Table 8. Global Cardiovascular Interventional Product Sales Market Share by Type (2018-2023)
Table 9. Global Cardiovascular Interventional Product Revenue by Type (2018-2023) & ($ million)
Table 10. Global Cardiovascular Interventional Product Revenue Market Share by Type (2018-2023)
Table 11. Global Cardiovascular Interventional Product Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Cardiovascular Interventional Product Sales by Application (2018-2023) & (K Units)
Table 13. Global Cardiovascular Interventional Product Sales Market Share by Application (2018-2023)
Table 14. Global Cardiovascular Interventional Product Revenue by Application (2018-2023)
Table 15. Global Cardiovascular Interventional Product Revenue Market Share by Application (2018-2023)
Table 16. Global Cardiovascular Interventional Product Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Cardiovascular Interventional Product Sales by Company (2018-2023) & (K Units)
Table 18. Global Cardiovascular Interventional Product Sales Market Share by Company (2018-2023)
Table 19. Global Cardiovascular Interventional Product Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Cardiovascular Interventional Product Revenue Market Share by Company (2018-2023)
Table 21. Global Cardiovascular Interventional Product Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Cardiovascular Interventional Product Producing Area Distribution and Sales Area
Table 23. Players Cardiovascular Interventional Product Products Offered
Table 24. Cardiovascular Interventional Product Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Cardiovascular Interventional Product Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Cardiovascular Interventional Product Sales Market Share Geographic Region (2018-2023)
Table 29. Global Cardiovascular Interventional Product Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Cardiovascular Interventional Product Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Cardiovascular Interventional Product Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Cardiovascular Interventional Product Sales Market Share by Country/Region (2018-2023)
Table 33. Global Cardiovascular Interventional Product Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Cardiovascular Interventional Product Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Cardiovascular Interventional Product Sales by Country (2018-2023) & (K Units)
Table 36. Americas Cardiovascular Interventional Product Sales Market Share by Country (2018-2023)
Table 37. Americas Cardiovascular Interventional Product Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Cardiovascular Interventional Product Revenue Market Share by Country (2018-2023)
Table 39. Americas Cardiovascular Interventional Product Sales by Type (2018-2023) & (K Units)
Table 40. Americas Cardiovascular Interventional Product Sales by Application (2018-2023) & (K Units)
Table 41. APAC Cardiovascular Interventional Product Sales by Region (2018-2023) & (K Units)
Table 42. APAC Cardiovascular Interventional Product Sales Market Share by Region (2018-2023)
Table 43. APAC Cardiovascular Interventional Product Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Cardiovascular Interventional Product Revenue Market Share by Region (2018-2023)
Table 45. APAC Cardiovascular Interventional Product Sales by Type (2018-2023) & (K Units)
Table 46. APAC Cardiovascular Interventional Product Sales by Application (2018-2023) & (K Units)
Table 47. Europe Cardiovascular Interventional Product Sales by Country (2018-2023) & (K Units)
Table 48. Europe Cardiovascular Interventional Product Sales Market Share by Country (2018-2023)
Table 49. Europe Cardiovascular Interventional Product Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Cardiovascular Interventional Product Revenue Market Share by Country (2018-2023)
Table 51. Europe Cardiovascular Interventional Product Sales by Type (2018-2023) & (K Units)
Table 52. Europe Cardiovascular Interventional Product Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Cardiovascular Interventional Product Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Cardiovascular Interventional Product Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Cardiovascular Interventional Product Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Cardiovascular Interventional Product Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Cardiovascular Interventional Product Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Cardiovascular Interventional Product Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Cardiovascular Interventional Product
Table 60. Key Market Challenges & Risks of Cardiovascular Interventional Product
Table 61. Key Industry Trends of Cardiovascular Interventional Product
Table 62. Cardiovascular Interventional Product Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Cardiovascular Interventional Product Distributors List
Table 65. Cardiovascular Interventional Product Customer List
Table 66. Global Cardiovascular Interventional Product Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Cardiovascular Interventional Product Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Cardiovascular Interventional Product Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Cardiovascular Interventional Product Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Cardiovascular Interventional Product Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Cardiovascular Interventional Product Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Cardiovascular Interventional Product Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Cardiovascular Interventional Product Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Cardiovascular Interventional Product Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Cardiovascular Interventional Product Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Cardiovascular Interventional Product Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Cardiovascular Interventional Product Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Cardiovascular Interventional Product Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Cardiovascular Interventional Product Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Boston Scientific Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 81. Boston Scientific Cardiovascular Interventional Product Product Portfolios and Specifications
Table 82. Boston Scientific Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Boston Scientific Main Business
Table 84. Boston Scientific Latest Developments
Table 85. Abbott Laboratories Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 86. Abbott Laboratories Cardiovascular Interventional Product Product Portfolios and Specifications
Table 87. Abbott Laboratories Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Abbott Laboratories Main Business
Table 89. Abbott Laboratories Latest Developments
Table 90. Medtronic plc Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 91. Medtronic plc Cardiovascular Interventional Product Product Portfolios and Specifications
Table 92. Medtronic plc Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Medtronic plc Main Business
Table 94. Medtronic plc Latest Developments
Table 95. TERUMO CORPORATION Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 96. TERUMO CORPORATION Cardiovascular Interventional Product Product Portfolios and Specifications
Table 97. TERUMO CORPORATION Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. TERUMO CORPORATION Main Business
Table 99. TERUMO CORPORATION Latest Developments
Table 100. NIPRO Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 101. NIPRO Cardiovascular Interventional Product Product Portfolios and Specifications
Table 102. NIPRO Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. NIPRO Main Business
Table 104. NIPRO Latest Developments
Table 105. B. Braun Melsungen AG Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 106. B. Braun Melsungen AG Cardiovascular Interventional Product Product Portfolios and Specifications
Table 107. B. Braun Melsungen AG Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. B. Braun Melsungen AG Main Business
Table 109. B. Braun Melsungen AG Latest Developments
Table 110. Cook Medical Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 111. Cook Medical Cardiovascular Interventional Product Product Portfolios and Specifications
Table 112. Cook Medical Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Cook Medical Main Business
Table 114. Cook Medical Latest Developments
Table 115. MicroPort Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 116. MicroPort Cardiovascular Interventional Product Product Portfolios and Specifications
Table 117. MicroPort Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. MicroPort Main Business
Table 119. MicroPort Latest Developments
Table 120. Lepu Medical Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 121. Lepu Medical Cardiovascular Interventional Product Product Portfolios and Specifications
Table 122. Lepu Medical Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Lepu Medical Main Business
Table 124. Lepu Medical Latest Developments
Table 125. JW Medical Systems (JWMS) Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 126. JW Medical Systems (JWMS) Cardiovascular Interventional Product Product Portfolios and Specifications
Table 127. JW Medical Systems (JWMS) Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. JW Medical Systems (JWMS) Main Business
Table 129. JW Medical Systems (JWMS) Latest Developments
Table 130. Intecc Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 131. Intecc Cardiovascular Interventional Product Product Portfolios and Specifications
Table 132. Intecc Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Intecc Main Business
Table 134. Intecc Latest Developments
Table 135. KANEKA Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 136. KANEKA Cardiovascular Interventional Product Product Portfolios and Specifications
Table 137. KANEKA Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. KANEKA Main Business
Table 139. KANEKA Latest Developments
Table 140. Sinomed Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 141. Sinomed Cardiovascular Interventional Product Product Portfolios and Specifications
Table 142. Sinomed Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Sinomed Main Business
Table 144. Sinomed Latest Developments
Table 145. Lifetech Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 146. Lifetech Cardiovascular Interventional Product Product Portfolios and Specifications
Table 147. Lifetech Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Lifetech Main Business
Table 149. Lifetech Latest Developments
Table 150. Gore Medical Basic Information, Cardiovascular Interventional Product Manufacturing Base, Sales Area and Its Competitors
Table 151. Gore Medical Cardiovascular Interventional Product Product Portfolios and Specifications
Table 152. Gore Medical Cardiovascular Interventional Product Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Gore Medical Main Business
Table 154. Gore Medical Latest Developments
List of Figures
Figure 1. Picture of Cardiovascular Interventional Product
Figure 2. Cardiovascular Interventional Product Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cardiovascular Interventional Product Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Cardiovascular Interventional Product Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Cardiovascular Interventional Product Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Coronary Stent
Figure 10. Product Picture of PTCA Balloon Catheter
Figure 11. Product Picture of Guide Wire
Figure 12. Product Picture of Other
Figure 13. Global Cardiovascular Interventional Product Sales Market Share by Type in 2022
Figure 14. Global Cardiovascular Interventional Product Revenue Market Share by Type (2018-2023)
Figure 15. Cardiovascular Interventional Product Consumed in Angina
Figure 16. Global Cardiovascular Interventional Product Market: Angina (2018-2023) & (K Units)
Figure 17. Cardiovascular Interventional Product Consumed in Miocardial Infarction
Figure 18. Global Cardiovascular Interventional Product Market: Miocardial Infarction (2018-2023) & (K Units)
Figure 19. Cardiovascular Interventional Product Consumed in Other
Figure 20. Global Cardiovascular Interventional Product Market: Other (2018-2023) & (K Units)
Figure 21. Global Cardiovascular Interventional Product Sales Market Share by Application (2022)
Figure 22. Global Cardiovascular Interventional Product Revenue Market Share by Application in 2022
Figure 23. Cardiovascular Interventional Product Sales Market by Company in 2022 (K Units)
Figure 24. Global Cardiovascular Interventional Product Sales Market Share by Company in 2022
Figure 25. Cardiovascular Interventional Product Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Cardiovascular Interventional Product Revenue Market Share by Company in 2022
Figure 27. Global Cardiovascular Interventional Product Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Cardiovascular Interventional Product Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Cardiovascular Interventional Product Sales 2018-2023 (K Units)
Figure 30. Americas Cardiovascular Interventional Product Revenue 2018-2023 ($ Millions)
Figure 31. APAC Cardiovascular Interventional Product Sales 2018-2023 (K Units)
Figure 32. APAC Cardiovascular Interventional Product Revenue 2018-2023 ($ Millions)
Figure 33. Europe Cardiovascular Interventional Product Sales 2018-2023 (K Units)
Figure 34. Europe Cardiovascular Interventional Product Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Cardiovascular Interventional Product Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Cardiovascular Interventional Product Revenue 2018-2023 ($ Millions)
Figure 37. Americas Cardiovascular Interventional Product Sales Market Share by Country in 2022
Figure 38. Americas Cardiovascular Interventional Product Revenue Market Share by Country in 2022
Figure 39. Americas Cardiovascular Interventional Product Sales Market Share by Type (2018-2023)
Figure 40. Americas Cardiovascular Interventional Product Sales Market Share by Application (2018-2023)
Figure 41. United States Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Cardiovascular Interventional Product Sales Market Share by Region in 2022
Figure 46. APAC Cardiovascular Interventional Product Revenue Market Share by Regions in 2022
Figure 47. APAC Cardiovascular Interventional Product Sales Market Share by Type (2018-2023)
Figure 48. APAC Cardiovascular Interventional Product Sales Market Share by Application (2018-2023)
Figure 49. China Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Cardiovascular Interventional Product Sales Market Share by Country in 2022
Figure 57. Europe Cardiovascular Interventional Product Revenue Market Share by Country in 2022
Figure 58. Europe Cardiovascular Interventional Product Sales Market Share by Type (2018-2023)
Figure 59. Europe Cardiovascular Interventional Product Sales Market Share by Application (2018-2023)
Figure 60. Germany Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Cardiovascular Interventional Product Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Cardiovascular Interventional Product Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Cardiovascular Interventional Product Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Cardiovascular Interventional Product Sales Market Share by Application (2018-2023)
Figure 69. Egypt Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Cardiovascular Interventional Product Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Cardiovascular Interventional Product in 2022
Figure 75. Manufacturing Process Analysis of Cardiovascular Interventional Product
Figure 76. Industry Chain Structure of Cardiovascular Interventional Product
Figure 77. Channels of Distribution
Figure 78. Global Cardiovascular Interventional Product Sales Market Forecast by Region (2024-2029)
Figure 79. Global Cardiovascular Interventional Product Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Cardiovascular Interventional Product Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Cardiovascular Interventional Product Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Cardiovascular Interventional Product Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Cardiovascular Interventional Product Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 心血管インターベンション製品のグローバル市場予測2023-2029(Global Cardiovascular Interventional Product Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

心血管インターベンション製品のグローバル市場予測2023-2029

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp